A G-quadruplex-forming RNA aptamer binds to the MTG8 TAFH domain and dissociates the leukemic AML1-MTG8 fusion protein from DNA.
Junichi FukunagaYusuke NomuraYoichiro TanakaHidetaka TorigoeYoshikazu NakamuraTaiichi SakamotoTomoko KozuPublished in: FEBS letters (2020)
MTG8 (RUNX1T1) is a fusion partner of AML1 (RUNX1) in the leukemic chromosome translocation t(8;21). The AML1-MTG8 fusion gene encodes a chimeric transcription factor. One of the highly conserved domains of MTG8 is TAFH which possesses homology with human TAF4 [TATA-box binding protein-associated factor]. To obtain specific inhibitors of the AML1-MTG8 fusion protein, we isolated RNA aptamers against the MTG8 TAFH domain using systematic evolution of ligands by exponential enrichment. All TAF aptamers contained guanine-rich sequences. Analyses of a TAF aptamer by NMR, CD, and mutagenesis revealed that it forms a parallel G-quadruplex structure in the presence of K+ . Furthermore, the aptamer could bind to the AML1-MTG8 fusion protein and dissociate the AML1-MTG8/DNA complex, suggesting that it can inhibit the dominant negative effects of AML1-MTG8 against normal AML1 function and serve as a potential therapeutic agent for leukemia.
Keyphrases
- acute myeloid leukemia
- transcription factor
- allogeneic hematopoietic stem cell transplantation
- binding protein
- gold nanoparticles
- nucleic acid
- endothelial cells
- single molecule
- sensitive detection
- bone marrow
- copy number
- crispr cas
- high resolution
- gene expression
- acute lymphoblastic leukemia
- cell free
- mass spectrometry
- genome wide
- mesenchymal stem cells
- circulating tumor
- dna binding
- induced pluripotent stem cells